Repare Therapeutics Inc.
RPTX
$1.59
$0.042.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -60.34% | -179.90% | 9.71% | 13.73% | -2,121.82% |
| Total Depreciation and Amortization | 58.25% | 29.59% | -1.54% | 3.84% | 5.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -54.72% | -10.59% | 2.57% | -19.94% | -12.72% |
| Change in Net Operating Assets | 81.58% | 82.12% | 74.53% | 72.71% | -11.37% |
| Cash from Operations | -29.81% | -40.83% | 39.88% | 39.93% | -945.96% |
| Capital Expenditure | -- | -- | -- | -321.11% | -362.79% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 108.53% | 49.64% | -38.15% | -37.33% | 128.46% |
| Cash from Investing | 110.45% | 53.04% | -36.61% | -37.97% | 128.18% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -67.80% | -69.40% | -35.63% | -28.38% | -13.87% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -67.80% | -69.40% | -35.63% | -28.38% | -13.87% |
| Foreign Exchange rate Adjustments | 194.92% | -289.47% | -627.27% | 113.77% | 83.52% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 65.95% | -2.84% | 44.98% | 43.90% | 77.71% |